Rausch V, Hackl M, Leschinger T, Müller L P, Wegmann K
Klinik und Poliklinik für Orthopädie und Unfallchirurgie, Schwerpunkt für Unfall‑, Hand- und Ellenbogenchirurgie, Uniklinik Köln, Kerpener Str. 62, 50937, Köln, Deutschland.
Z Rheumatol. 2018 Dec;77(10):899-906. doi: 10.1007/s00393-018-0539-x.
When the elbow is destroyed due to rheumatic diseases, the joint can be replaced by a prosthesis and total arthroplasty. Improved pharmaceutical treatment for rheumatic diseases has, however, reduced the number of implantations in these patients. Reported 10-year survival rates of the implant currently achieve 81-90%.; however, due to limited long-term survival of the implant and high complication rates, total elbow arthroplasty should still be used with caution. Continuous technical improvements in the available prostheses and in surgical techniques could lead in the future to a decline in complications, such as aseptic loosening and infections.
当肘部因风湿性疾病而遭到破坏时,可通过假体置换和全关节成形术来替换关节。然而,针对风湿性疾病的药物治疗有所改进,已减少了这些患者的植入手术数量。目前报道的该植入物10年生存率达到81% - 90%;然而,由于植入物的长期生存率有限且并发症发生率高,全肘关节置换术仍应谨慎使用。现有假体和手术技术的持续技术改进未来可能会导致并发症(如无菌性松动和感染)减少。